arrow
A

Andrea Visentin

University of Padua
H指数:28
被引数:2,941

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

更正:携带t(14;19)易位的慢性淋巴细胞白血病患者临床和转录组学特征:一项ERIC研究

Leukemia
IF13.4
2026-10-160
OAAI
Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy

吡柔比星在里奇特综合征中的应用:来自意大利指定患者项目的结果

2026-09-060
OAAI
Minimal residual disease–guided ibrutinib and venetoclax in patients with chronic lymphocytic leukaemia and complex karyotype

微小残留病指导下的伊布替尼和维奈克拉在伴有复杂核型的慢性淋巴细胞白血病患者中的应用

2026-09-050
OAAI
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol

无放射治疗对低代谢肿瘤体积和2个化疗周期后中期PET阴性定义的良好预后早期非巨大肿块霍奇金淋巴瘤初始治疗的RAFTING试验方案

2026-08-290
OA
Long-term results of the HD0607 trial on interim PET-adapted treatment of advanced-stage Hodgkin lymphoma beyond 10 years of follow-up

HD0607试验中关于晚期霍奇金淋巴瘤中期PET调整治疗的10年以上随访长期结果

2026-07-140
OAAI
Joint Assessment of CD38, CD138, and Immunoglobulin Light Chains Supports the Differential Diagnosis Between Classical Hodgkin Lymphoma and Plasmablastic Lymphoma

联合评估CD38、CD138和免疫球蛋白轻链支持经典霍奇金淋巴瘤与浆细胞样淋巴瘤的鉴别诊断

2026-03-010
PRE
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation

解析慢性淋巴细胞白血病的髓系克隆性造血及其里奇转化

2026-02-160
OAAI
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice

重新思考维奈克拉-奥滨尤妥珠单抗在慢性淋巴细胞白血病中的可行性与安全性:非传统因素可能在临床实践中发挥作用

2026-01-014
OA
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R)

vemurafenib联合利妥昔单抗治疗复发或难治性毛细胞白血病的真实世界疗效与安全性:一项多中心意大利回顾性研究(HCL-PG03R)

2025-11-140
OAAI
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib—A Case Report and a Review of the Literature

毛细胞白血病的不常见定位:中枢神经系统受累及伊布替尼的治疗反应——病例报告及文献综述

2025-10-310
OAAI
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病中中枢神经系统受累:ERIC(欧洲慢性淋巴细胞白血病研究倡议)国际回顾性研究

2025-10-280
OAAI
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia

CD19 CAR T细胞疗法在Richter转化中的研究:欧洲慢性淋巴细胞白血病研究倡议进行的 multicentre 回顾性分析

2025-10-220
OAAI
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

携带t(14;19)易位的慢性淋巴细胞白血病患者临床及转录组学特征:一项ERIC研究

Leukemia
IF13.4
2025-09-190
OAAI
Interplay Between Protein Phosphatase 2A (PP2A) and SE Translocation (SET) as Macromolecular Target of Anticancer Compounds: A Combined Computational and Experimental Study

蛋白磷酸酶2A(PP2A)与SE易位(SET)的相互作用作为抗癌化合物的大分子靶点:一项结合计算和实验的研究

2025-09-120
OA
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring

毛细胞白血病中血清可溶性白细胞介素-2受体水平作为肿瘤负荷标志物,具有预后价值,并作为疾病监测工具。

2025-07-290
OAAI
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

特定疾病的U1剪接体RNA突变在成熟B细胞肿瘤中

Leukemia
IF13.4
2025-06-300
OAAI
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes

慢性淋巴细胞白血病患者接受伊布替尼治疗的弥漫性大b细胞淋巴瘤的Richter转化: 危险因素和结果

Leukemia
IF13.4
2025-06-250
OAAI
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study

家族性慢性淋巴细胞白血病比散发性形式的预后更差:一项意大利病例对照研究

2025-06-140
OAAI